Quick Links

How to Find Us

Division of Rheumatology
1959 NE Pacific St
Health Science Bldg BB561
Campus Box 356428
Seattle, WA 98195

Email Us

Phone: 206-543-3414

Click here for directions & other rheumatology locations.


Edward A. Clark, Ph.D.


Professor, Department of Microbiology
Professor, Department of Immunology
Adjunct Professor of Medicine

750 Republican Street
Box 358059, Room E343
Seattle, WA 98109
Phone: 206-543-8706
Fax: 206-616-4274
Email: eaclark@uw.edu




  • B.A., Psychology and Zoology, University of California, Los Angeles
  • Ph.D., Microbiology/Immunology, University of California, Los Angeles



  • Adaptive Immune Responses
  • Infectious Diseases
  • Innate Immunity
  • Tolerance & Autoimmunity


A major goal of Dr. Clark’s lab has been to define receptors and ligands regulating B cells and dendritic cells (DCs) and to help translate findings for use in clinical immunology. His lab helped discover and characterize human B cell/DC-associated surface molecules like CD20, CD22, CD40, CD80 (B7.1), CD150 (SLAM) and CD180 (RP105). Recently, the lab has focused on defining C-type lectin receptors (CLRs) on DCs including DCAL2, which is a useful marker to identify and isolate DC subsets. In order to assess the function of CLRs and their possible use for vaccine development, Dr. Clark’s lab has coupled antigens (Ags) to monoclonal antibodies (mAbs) specific for CLRs expressed on DC subsets. The Ag-mAb conjugates are inoculated into mice as a kind of ‘antigen-delivery system’, which enables Ags to be selectively targeted to a particular DC subset, which then responses and programs an appropriate, protective immune response. Targeting antigens to DCIR2 or CD180, in particular, induces strong and rapid antibody responses and has great potential in platforms for vaccines.


B cells are very social cells; their behavior is influenced not only by T cells, but also by Ag presented in different forms including in association with DCs or macrophages. DCs and macrophages also produce cytokines like BAFF, which are essential for B cell survival and maturation. The Clark lab investigates how DCs regulate B cell responses. Current projects in this area include: 1) defining the role CD22 and other B cell/DC-associated receptors play in protective immune responses to West Nile virus; 2) characterizing how TLR7 regulates and dysregulates B cell development and antibody production; 3) defining how DCs program B cells to develop extrafollicular Ab responses or germinal centers and long-lived humoral immunity; 4) investigating how BAFF from different cell sources regulates B cell responses to Ag.





  • Porakishvili N, Vispute K, Steele AJ, Rajakaruna N, Kulikova N, Tsertsvadze T, Nathwani A, Damle RN, Clark EA, Rai KR, Chiorazzi N, Lydyard PM.Rewiring of sIgM-mediated intracellular signaling through the CD180 Toll-like receptor. Mol Med. 2015 Jan 14. doi: 10.2119/molmed.2014.00265. [Epub ahead of print] PMID: 25611435

  • Hughes GC, Thomas S, Li C, Kaja MK, Clark EA. Progesterone regulates IFN-α production by plasmacytoid dendritic cells, J Immunol Cutting Edge, 180:2029-2033, 2008.
  • Hughes GC, Martin DA, Zhang K, Alpers CE, Clark EA, Elkon KB. Progesterone treatment of lupus-prone NZB/W mice decreases glomerulonephritis and TH1-associated autoantibody production, Arthritis Rheum 60:1775-1784, 2009.
  • Ma D, Clark EA. Role of CD40 and CD40L in dendritic cells, Seminars Immunol 21:265-272, 2009.
  • Suthar MS, Ma D, Thomas S, Daffis S, Lund J, Zhang N, Rudensky AY, Bevan MJ, Clark EA, Krisha-Kaja M, Diamond MS, Gale Jr M. IPS-1 is essential for the control of West Nile virus infection and immunity, PLos Pathogens, 6:e1000757, 2010.
  • Yurchenko MY, Kovalevska LM, Shlapatska LM, Berdova GG, Clark EA, Sidorenko SP. CD150 regulates JNK1/2 activation in normal and Hodgkin’s lymphoma B cells, Immunol Cell Biol, 88:565-74, 2010.
  • Giordano D, Li C, Suthar MS, Draves KE, Ma DY, Gale MG Jr, Clark EA. Role of nitric oxide in dendritic cell survival, cytokine production and induction of Th17 and Th1 T cell responses, J Leukocyte Biol, 89: 443-455, 2011.
  • Porakishvili N, Memon A, Vispute K, Kulikova N, Clark EA, Rai K, Nathwani A, Damle RN, Chiorazzi N, Lydyard PM. CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells, Bri J Hematol 153:486-498, 2011.
  • Kasahara S, Clark EA. Dendritic cell-associated lectin 2 (DCAL2) defines a distinct CD8α- dendritic cell subset, J Leukocyte Biol, 91:437-448, 2012.
  • Chappell CP, Draves KE, Giltiay NV, Clark EA. Extrafollicular B cell activation by marginal zone dendritic cells drives T cell-dependent antibody responses, J Exp Med, 209:1825-1849, 2012.
  • Giltiay NV, *Chappell CP, Clark EA. B cell selection and the development of autoantibodies, Arth Res Therapy, 14(Suppl 4):S1, 2012.
  • Ma DY, Suthar MS, Kasahara S, Gale M Jr, Clark EA. CD22 is required for protection against West Nile virus infection, J Virol, 87: 3361-3375, 2013.
  • Chaplin JW, Chappell CP, Clark EA. Targeting antigens to CD180 rapidly induces antigen-specific IgG, affinity maturation and immunologic memory, J Exp Med, in press, 2013.



Quick Links:

Elkon Lab | Division Publications | Clinical Faculty



Go to top